D’Andrea, D., & Sewesll, R. A. (2013). Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion. Biological Psychiatry, 74(9), e13–e14.
Highlights:
- An N-methyl-D-aspartate (NMDA) receptor antagonist with μ-opioid receptor effects, ketamine causes depression remission in most clinical trials attracting interest as a rapid-acting antidepressant
- We describe a case in which ketamine was given for treatment-resistant depression, but that caused serendipitous resolution of posttraumatic stress disorder (PTSD) symptoms.
